• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Verve Therapeutics, Inc. - Common Stock (NQ:VERV)

11.12 +0.04 (+0.32%)
Streaming Delayed Price Updated: 2:49 PM EDT, Jul 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,443,249
Open 11.11
Bid (Size) 11.11 (105)
Ask (Size) 11.12 (137)
Prev. Close 11.08
Today's Range 11.08 - 11.13
52wk Range 2.865 - 11.40
Shares Outstanding 61,930,485
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
3 Bullish Biotech Stocks With Explosive Growth Trends
July 21, 2025
These small-cap biotech stocks offer high-reward potential with bullish momentum and key catalysts ahead in urology, autoimmune, and gene editing therapies 
Via MarketBeat
Goldman Spotlights These 3 Stocks in Its Bullish S&P 500 Outlook
July 15, 2025
Goldman Sachs raised its year-end S&P 500 forecast and identified three stocks that are poised to outperform in the second half of 2025: KSS, NTLA, and GOGO. 
Via MarketBeat
Topics Economy Stocks

Performance

YTD
+84.9%
+84.9%
1 Month
+0.0%
+0.0%
3 Month
+111.7%
+111.7%
6 Month
+69.2%
+69.2%
1 Year
+54.8%
+54.8%

More News

Read More
VERVE THERAPEUTICS INC (NASDAQ:VERV) - A High-Growth Biotech Stock Meeting Minervini's Criteria
July 09, 2025
Via Chartmill
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Verve Therapeutics, Inc. (Nasdaq - VERV), Sage Therapeutics, Inc. (Nasdaq - SAGE), Cantaloupe, Inc. (Nasdaq - CTLP), Volato Group, Inc. (NYSE American - SOAR)
June 27, 2025
From Brodsky & Smith LLC
Via GlobeNewswire
Why Lilly's Bid for Verve Therapeutics Sent the Stock Soaring This Week
June 20, 2025
Via The Motley Fool
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CTLP, VERV, CVAC on Behalf of Shareholders
June 20, 2025
From Halper Sadeh LLC
Via GlobeNewswire
VERVE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Verve Therapeutics, Inc. - VERV
June 18, 2025
From Kahn Swick & Foti, LLC
Via Business Wire
Eli Lilly's $1.3 Billion Verve Deal Signals Confidence In Gene Editing Space: Analyst
June 18, 2025
Via Benzinga
This Verve Therapeutics Analyst Is No Longer Bullish; Here Are Top 4 Downgrades For Wednesday
June 18, 2025
Via Benzinga
Market Monitor News June 18 (Jabil, Reddit & Verve Therapeutics UP - Solar Stocks First Solar, Sunrun & SolarEdge DOWN)
June 18, 2025
Via Chartmill
5 Analysts Assess Verve Therapeutics: What You Need To Know
June 17, 2025
Via Benzinga
These stocks are moving in today's session
June 17, 2025
Via Chartmill
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VERV, SAGE, CTLP, SOAR on Behalf of Shareholders
June 17, 2025
From Halper Sadeh LLC
Via GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
June 17, 2025
Via Benzinga
Which stocks are moving on Tuesday?
June 17, 2025
Via Chartmill
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Verve Therapeutics, Inc. (Nasdaq - VERV), Sage Therapeutics, Inc. (Nasdaq - SAGE), Cantaloupe, Inc. (Nasdaq - CTLP), Volato Group, Inc. (NYSE American - SOAR)
June 17, 2025
From Brodsky & Smith LLC
Via GlobeNewswire
VERV Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Verve Therapeutics, Inc. Is Fair to Shareholders
June 17, 2025
From Halper Sadeh LLC
Via Business Wire
Why Verve Therapeutics Stock Is Skyrocketing Today
June 17, 2025
Via The Motley Fool
Jabil Posts Upbeat Earnings, Joins Verve Therapeutics, John Wiley & Sons And Other Big Stocks Moving Higher On Tuesday
June 17, 2025
Via Benzinga
Which stocks are gapping on Tuesday?
June 17, 2025
Via Chartmill
Power Metallic (TSX.V: PNPN) Secures Largest Saudi License Amid June 2025 Gold Surge – Material Gains & More Stocks Inside
June 17, 2025
Via AB Newswire
Verve Therapeutics Stock Rockets 75% Pre-Market After Eli Lilly Agrees To Acquire The Company For Up To $1.3B: Retail Says Offer Is ‘Low’
June 17, 2025
Via Stocktwits
Verve Therapeutics Skyrockets — Pulling Gene-Editing Stocks Higher — On $1.3 Billion Eli Lilly Takeover
June 17, 2025
Via Investor's Business Daily
Top 3 Health Care Stocks That Are Ticking Portfolio Bombs
June 17, 2025
Via Benzinga
Get insights into the top gainers and losers of Tuesday's pre-market session.
June 17, 2025
Via Chartmill

Frequently Asked Questions

Is Verve Therapeutics, Inc. - Common Stock publicly traded?
Yes, Verve Therapeutics, Inc. - Common Stock is publicly traded.
What exchange does Verve Therapeutics, Inc. - Common Stock trade on?
Verve Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Verve Therapeutics, Inc. - Common Stock?
The ticker symbol for Verve Therapeutics, Inc. - Common Stock is VERV on the Nasdaq Stock Market
What is the current price of Verve Therapeutics, Inc. - Common Stock?
The current price of Verve Therapeutics, Inc. - Common Stock is 11.12
When was Verve Therapeutics, Inc. - Common Stock last traded?
The last trade of Verve Therapeutics, Inc. - Common Stock was at 07/23/25 02:49 PM ET
What is the market capitalization of Verve Therapeutics, Inc. - Common Stock?
The market capitalization of Verve Therapeutics, Inc. - Common Stock is 688.36M
How many shares of Verve Therapeutics, Inc. - Common Stock are outstanding?
Verve Therapeutics, Inc. - Common Stock has 688M shares outstanding.
Site Logo
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap